4.7 Article

Transcription Factor/microRNA Axis Blocks Melanoma Invasion Program by miR-211 Targeting NUAK1

期刊

JOURNAL OF INVESTIGATIVE DERMATOLOGY
卷 134, 期 2, 页码 441-451

出版社

ELSEVIER SCIENCE INC
DOI: 10.1038/jid.2013.340

关键词

-

资金

  1. The Israeli Centers for Research Excellence (I-CORE)
  2. Israel Cancer Association (ICA)
  3. Israel Cancer Research Fund (ICRF)
  4. US-Israel Binational Science Fund (BSF)
  5. Fritz Thyssen Stiftung
  6. Marie Curie Career Integration Grants (CIG)
  7. Dalya Gridinger Fund
  8. Fingerhot Carol
  9. Lionara Fund
  10. Shtacher Family Award
  11. Israel Cancer Research Fund
  12. Raymond and Beverly Sackler Chair in Bioinformatics
  13. Edmond J. Safra Center for Bioinformatics at Tel Aviv University

向作者/读者索取更多资源

Melanoma is one of the deadliest human cancers, responsible for approximately 80% of skin cancer mortalities. The aggressiveness of melanoma is due to its capacity to proliferate and rapidly invade surrounding tissues, leading to metastases. A recent model suggests melanoma progresses by reversibly switching between proliferation and invasion transcriptional signatures. Recent studies show that cancer cells are more sensitive to microRNA (miRNA) perturbation than are non-cancer cells; however, the roles of miRNAs in melanoma plasticity remain unexplored. Here, we use the gene expression profiles of melanoma and normal melanocytes to characterize the transcription factor miRNA relationship that modulates the proliferative and invasive programs of melanoma. We identified two sets of miRNAs that likely regulate these programs. Interestingly, one of the miRNAs involved in melanoma invasion is miR-211, a known target of the master regulator microphthalmia-associated transcription factor (MITF). We demonstrate that miR-211 contributes to melanoma adhesion by directly targeting a gene, NUAK1. Inhibition of miR-211 increases NUAK1 expression and decreases melanoma adhesion, whereas upregulation of miR-211 restores adhesion through NUAK1 repression. This study defines the MITF/miR-211 axis that inhibits the invasive program by blocking adhesion. Furthermore, we have identified NUAK1 as a potential target for the treatment of metastatic melanoma.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据